Literature mining and bioinformatics analysis of <italic style="font-style: italic">Xue Xue’s Medical Cases </italic>for differentiation and treatment of gastrointestinal diseases

SU Haiyang; ZHANG Yang; TU Yanjie; YANG Aidong

doi:10.16306/j.1008-861x.2023.01.011

您当前的位置：

首页 >

文章列表页 >

Literature mining and bioinformatics analysis of Xue Xue’s Medical Cases for differentiation and treatment of gastrointestinal diseases

Experiment Research | 更新时间：2023-02-14

- Literature mining and bioinformatics analysis of Xue Xue’s Medical Cases for differentiation and treatment of gastrointestinal diseases
- Academic Journal of Shanghai University of Traditional Chinese Medicine Vol. 37, Issue 1, Pages: 75-84(2023)
- 作者机构：
  
  1.上海中医药大学（上海　201203）
  2.上海中医药大学科技信息中心（上海　201203）
  3.上海中医药大学基础医学院（上海　201203）
  4.上海市重大传染病和生物安全研究院中医药疫病研究中心（上海　200032）
- 作者简介：
- 基金信息：
- DOI：10.16306/j.1008-861x.2023.01.011
  CLC：
扫描看全文
苏海洋,张洋,屠燕捷等.《薛雪医案》辨治胃肠疾病的文献挖掘与生物信息学分析[J].上海中医药大学学报,2023,37(01):75-84.

SU Haiyang,ZHANG Yang,TU Yanjie,et al.Literature mining and bioinformatics analysis of Xue Xue’s Medical Cases for differentiation and treatment of gastrointestinal diseases[J].Academic Journal of Shanghai University of Traditional Chinese Medicine,2023,37(01):75-84.
苏海洋,张洋,屠燕捷等.《薛雪医案》辨治胃肠疾病的文献挖掘与生物信息学分析[J].上海中医药大学学报,2023,37(01):75-84. DOI： 10.16306/j.1008-861x.2023.01.011.

SU Haiyang,ZHANG Yang,TU Yanjie,et al.Literature mining and bioinformatics analysis of Xue Xue’s Medical Cases for differentiation and treatment of gastrointestinal diseases[J].Academic Journal of Shanghai University of Traditional Chinese Medicine,2023,37(01):75-84. DOI： 10.16306/j.1008-861x.2023.01.011.

摘要

目的,2,基于中医传承辅助平台及网络药理学分析《薛雪医案》中辨治胃肠疾病的遣方用药特点及内在机制，为临床以湿热类胃肠病为代表的消化系统疾病中医诊治提供参考。,方法,2,筛选《薛雪医案》中辨治胃肠疾病相关医案，数据标准化处理后录入中医传承辅助平台分析药物频次、组方规律等，获得核心药物组合。对核心药物组合进行蛋白质相互作用（PPI）分析、基因本体（GO）及京都基因与基因组百科全书（KEGG）富集分析，探讨核心药物组合治疗胃肠疾病的作用机制。,结果,2,①共纳入《薛雪医案》中辨治胃肠疾病医案191则，涉及中药219味。综合药物频次、组方规律及新方分析确定厚朴、草果、人参、茯苓、陈皮、大腹皮、白术、广藿香为核心药物组合。②PPI分析显示，度值较高的蛋白包括蛋白激酶B α（Akt1）、肿瘤坏死因子（TNF）、肿瘤蛋白p53（TP53）、血管内皮生长因子A（VEGFA）、原癌基因酪氨酸蛋白激酶Src（Src）、热休克蛋白90α家族A类成员1（HSP90AA1）等，涉及磷脂酰肌醇-3-激酶/蛋白激酶B（PI3K/Akt）信号通路、缺氧诱导因子-1（HIF-1）信号通路、VEGF信号通路、癌症通路等。,结论,2,从《薛雪医案》中分析并总结出薛氏辨治胃肠疾病核心药物组合，其具有苦燥芳化、健脾理气之功，通过多成分、多靶点、多通路发挥抗炎、抗肿瘤、抗氧化、抑菌等作用。

Abstract

Objective： To analyze the characteristics and internal mechanism of Xue Shengbai’s prescriptions for the differentiation and treatment of gastrointestinal diseases in ,Xue Xue’s Medical Cases, based on the traditional Chinese medicine inheritance auxiliary platform （TCMIAP） and network pharmacology， thus providing reference for traditional Chinese medicine diagnosis and treatment of digestive system diseases represented by damp-heat gastrointestinal diseases.,Methods,2,Medical cases related to differentiation and treatment of gastrointestinal diseases in ,Xue Xue’s Medical Cases, were screened， and these data were standardized and entered into TCMIAP to analyze the drug frequency， prescription rules， etc. The core drug combination was obtained and analyzed by protein-protein interaction （PPI） analysis， Gene Ontology （GO） and Kyoto Encyclopedia of Genes and Genomes （KEGG） enrichment analysis， to explore its mechanism in the treatment of gastrointestinal diseases.,Results,2,①A total of 191 medical cases of differentiation and treatment of gastrointestinal diseases in ,Xue Xue’s Medical Cases, were included， involving 219 traditional Chinese medicines. According to the drug frequency， prescription rules and new prescription analysis， the core drug combination was confirmed as follow： Magnoliae Officinalis Cortex， Tsaoko Fructus， Ginseng Radix Et Rhizoma， Poria， Citri Reticulatae Pericarpium， Arecae Pericarpium， Atractylodis Macrocephalae Rhizoma， Pogostemonis Herba. ②PPI analysis showed that proteins with high degree values included protein kinase Bα （Akt1）， tumor necrosis factor （TNF）， tumor protein p53 （TP53）， vascular endothelial growth factor A （VEGFA）， proto-oncogene tyrosine-protein kinase Src （Src）， heat shock protein 90 α family class A member 1 （HSP90AA1）， etc. And pathways such as phosphatidylinositol 3-kinase/protein kinase B （PI3K/Akt） signaling pathway， hypoxia inducible factor-1 （HIF-1） signaling pathway， VEGF signaling pathway， cancer pathway were involved.,Conclusion,2,Based on the analysis and summary of ,Xue Xue's Medical Cases，, the core drug combination for the differentiation and treatment of gastrointestinal diseases was summarized， which has the function of drying dampness by bitter herbs and resolving dampness by aromatic herbs， invigorating spleen and regulating qi， and exerts therapeutic effects such as anti-inflammation， anti-tumor， anti-oxidation， anti-bacteria through multi-component， multi-target and multi-pathway.

关键词

薛生白胃肠疾病中医传承辅助平台网络药理学

Keywords

Xue Shengbaigastrointestinal diseasestraditional Chinese medicine inheritance auxiliary platformnetwork pharmacology

references

赵尔巽. 清史稿·列传二百八十九［M］. 上海：上海古籍出版社，2018： 10383.

ZHAO E X. Biography 289th of Qing History Draft［M］. Shanghai：Shanghai Classics Publishing House， 2018： 10383.

薛雪. 薛雪医案［M］. 北京：北京科学技术出版社，2014.

XUE X. Xue Xue’s Medical Cases［M］. Beijing：Beijing Science and Technology Press， 2014.

国家卫生健康委员会办公厅，国家中医药管理局办公室. 新型冠状病毒肺炎诊疗方案（试行第九版）［J］. 江苏中医药，2022， 54（4）： 2-6.

General Office of National Health Commission， Office of National Administration of Traditional Chinese Medicine. Diagnosis and treatment plan for COVID-19 （Trial Ninth Edition）［J］. Jiangsu Journal of Traditional Chinese Medicine， 2022， 54（4）： 2-6.

国家药典委员会. 中华人民共和国药典（2020年版）（一部）［M］. 北京：中国医药科技出版社，2020.

Chinese Pharmacopoeia Commission. Pharmacopoeia of the People’s Republic of China （2020 Edition）（Volume 1）［M］. Beijing：China Medical Science Press，2020.

李经纬. 中医大辞典［M］. 北京：人民卫生出版社，2005.

LI J W. Dictionary of Traditional Chinese Medicine［M］. Beijing：People’s Medical Publishing House， 2005.

杨洪军，唐仕欢，卢朋. 中医传承辅助平台的开发与应用［M］. 福州：福建科学技术出版社，2013.

YANG H J，TANG S H，LU P. Development and Application of the Traditional Chinese Medicine Inheritance Auxiliary Platform［M］. Fuzhou：Fujian Science and Technology Publishing House， 2013.

RU J，LI P， WANG J，et al. TCMSP： a database of systems pharmacology for drug discovery from herbal medicines［J］. J Cheminform，2014， 6： 13.

汝锦龙. 中药系统药理学数据库和分析平台的构建和应用［D］. 咸阳：西北农林科技大学，2015： 10-11.

RU J L. Construction and utilization of traditional Chinese medicine systems pharmacology database and analysis platform［D］. Xianyang：Northwest Agriculture and Forestry University，2015： 10-11.

KIM S. Exploring Chemical Information in PubChem［J］. Curr Protoc， 2021， 1（8）： e217.

DAINA A，MICHIELIN O，ZOETE V. SwissTargetPrediction： updated data and new features for efficient prediction of protein targets of small molecules［J］. Nucleic Acids Res， 2019， 47（W1）： W357-W364.

WISHART D S， FEUNANG Y D，GUO A C，et al. DrugBank 5.0： a major update to the DrugBank database for 2018［J］. Nucleic Acids Res， 2018， 46（D1）： D1074-D1082.

STELZER G，ROSEN N，PLASCHKES I，et al. The GeneCards Suite： From Gene Data Mining to Disease Genome Sequence Analyses［J］. Curr Protoc Bioinformatics， 2016， 54： 1.30.1-1.30.33.

UNIPROT CONSORTIUM. UniProt： the universal protein knowledgebase in 2021［J］. Nucleic Acids Res， 2021， 49（D1）： D480-D489.

JIA A， XU L，WANG Y. Venn diagrams in bioinformatics［J］. Brief Bioinform， 2021， 22（5）： bbab108.

SZKLARCZYK D，GABLE A L，NASTOU K C，et al. The STRING database in 2021： customizable protein-protein networks，and functional characterization of user-uploaded gene/measurement sets［J］. Nucleic Acids Res， 2021， 49（D1）： D605-D612.

KOHL M， WIESE S，WARSCHEID B. Cytoscape： software for visualization and analysis of biological networks［J］. Methods Mol Biol， 2011， 696： 291-303.

DENNIS G J R， SHERMAN B T， HOSACK D A， et al. DAVID： Database for Annotation， Visualization， and Integrated Discovery［J］. Genome Biol， 2003， 4（5）： P3.

杜文燮. 药鉴［M］. 北京：中国中医药出版社，2016：59.

DU W X. Drug Identification［M］. Beijing：China Traditional Chinese Medicine Publishing House， 2016： 59.

薛雪. 湿热论［M］. 北京：人民卫生出版社，2007：53，56.

XUE X. Treatise on Dampness and Heat［M］. Beijing：People’s Medical Publishing House， 2007： 53， 56.

刘小玉，李玉娟，姜厚望，等. 叶天士与薛生白治疗湿热下利的用药特色分析［J］. 中国中药杂志，2018，43（8）：1720-1725.

LIU X Y，LI Y J，JIANG H W，et al. Comparison between Ye Tianshi and Xue Shengbai in treatment of diarrfea with damp-heat［J］. China Journal of Chinese Materia Medica， 2018， 43（8）： 1720-1725.

牟晋珠. 表儿茶素镇痛抗炎作用与机理研究［D］. 大庆：黑龙江八一农垦大学，2016.

MU J Z. Research on the analgesic and anti-inflammatory effect of epicatechin and its mechanism［D］. Daqing： Heilongjiang Bayi Agricultural University， 2016.

李聪，胡强，张燕翔，等. 槲皮素的药理学活性研究进展［J］. 湖北中医杂志，2018， 40（6）： 63-66.

LI C，HU Q， ZHANG Y X， et al. Research progress on pharmacological activity of quercetin［J］. Hubei Journal of Traditional Chinese Medicine，2018， 40（6）： 63-66.

孙玉成，刘晓巍，片光哲. β-谷甾醇诱导人胃癌细胞自噬与凋亡的作用及机制研究［J］. 中国医师杂志，2019， 21（6）： 866-871.

SUN Y C，LIU X W，PIAN G Z. Effect and mechanism study on the autophagy and apoptosis induced by β-sitosterol in human gastic cancer cells［J］. Journal of Chinese Physician， 2019， 21（6）： 866-871.

ALAM M B，CHOWDHURY N S，SOHRAB M H，et al. Cerevisterol Alleviates Inflammation via Suppression of MAPK/NF-κB/AP-1 and Activation of the Nrf2/HO-1 Signaling Cascade［J］. Biomolecules， 2020， 10（2）： 199.

杨雪竹，张浩，崔西玉，等. 川陈皮素抑制胃癌SGC-7901细胞侵袭能力的机制探讨［J］. 现代肿瘤医学，2020， 28（18）： 3099-3104.

YANG X Z，ZHANG H，CUI X Y，et al. Study on the mechanism of nobiletin inhibiting the invasiveness of SGC-7901 gastric cancer cells［J］. Journal of Modern Oncology， 2020， 28（18）： 3099-3104.

HAO X，LIU Y，ZHOU P，et al. Integrating Network Pharmacology and Experimental Validation to Investigate the Mechanisms of Huazhuojiedu Decoction to Treat Chronic Atrophic Gastritis［J］. Evid Based Complement Alternat Med， 2020， 2020： 2638362.

EL-TAHAN R R，GHONEIM A M，EL-MASHAD N. TNF-α gene polymorphisms and expression［J］. Springerplus，2016， 5（1）： 1508.

YU R，SUN T，ZHANG X，et al. TP53 Co-Mutational Features and NGS-Calibrated Immunohistochemistry Threshold in Gastric Cancer［J］. Onco Targets Ther， 2021， 14： 4967-4978.

GOBBO CÉSAR A C，DE FREITAS CALMON M，CURY P M，et al. Genetic alterations in benign lesions： chronic gastritis and gastric ulcer［J］. World J Gastroenterol， 2006， 12（4）： 625-629.

GAO X，MA F，HAO H，et al. Association of VEGFA polymorphisms with necrotizing enterocolitis in Chinese Han population［J］. Pediatr Neonatol， 2019， 60（2）： 129-134.

ROSKOSKI R J R. Src protein-tyrosine kinase structure， mechanism， and small molecule inhibitors［J］. Pharmacol Res，2015， 94： 9-25.

XIAO X，WANG W，LI Y，et al. HSP90AA1-mediated autophagy promotes drug resistance in osteosarcoma［J］. J Exp Clin Cancer Res， 2018， 37（1）： 201.

NAM H H，KIM J S，LEE J，et al. Pharmacological Effects of Agastache rugosa against Gastritis Using a Network Pharmacology Approach［J］. Biomolecules， 2020， 10（9）： 1298.

MATAK P，HEINIS M，MATHIEU J R，et al. Myeloid HIF-1 is protective in Helicobacter pylori-mediated gastritis［J］. J Immunol， 2015， 194（7）： 3259-3266.

FACHI J L，FELIPE J S，PRAL L P，et al. Butyrate Protects Mice from Clostridium difficile-Induced Colitis through an HIF-1-Dependent Mechanism［J］. Cell Rep， 2019， 27（3）： 750-761，e1-e7.

WEN J X，TONG Y L，MA X，et al. Therapeutic effects and potential mechanism of dehydroevodiamine on N-methyl-N'-nitro-N-nitrosoguanidine-induced chronic atrophic gastritis［J］. Phytomedicine， 2021， 91： 153619.

张梦娜. 厚朴叶和厚朴籽化学成分分析及生物活性研究［D］. 绵阳：西南科技大学，2019.

ZHANG M N. Analysis of chemical constituents and biological activities of magnolia officinalis leaves and seeds［D］. Mianyang Southwest University of Science and Technology， 2019.

刘谚哲. 人参多糖对大鼠乙醇诱导胃黏膜损伤的保护作用及机制研究［D］. 长春：吉林大学，2020.

LIU Y Z. Gastroprotective effects and mechanisms of ginseng polysaccharide on ethanol-induced injury in rats［D］. Changchun Jilin University， 2020.

秦劭晨，王爱梅，李若瑜. 茯苓酸对TNF-α诱导SH-SY5Y细胞炎症氧化应激反应和凋亡的拮抗作用研究［J］. 中国中医药科技，2019， 26（06）： 854-858.

QIN S C，WANG A M，LI R Y. Effects of pachymic acid on inflammation， oxidative stress injury and apoptosis of SH-SY5Y cells induced by TNF-α［J］. Chinese Journal of Traditional Medical Science and Technology， 2019， 26（06）： 854-858.

柳威，邓林华，赵英强. 白术及其有效成分药理作用概述［J］. 中医药学报，2021， 49（10）： 116-119.

LIU W，DENG L H，ZHAO Y Q. Summary of pharmacological effects of atractylodes macrocephala and its active ingredients［J］. Acta Chinese Medicine and Pharmacology， 2021， 49（10）： 116-119.

Views

151

下载量

CSCD

CNKI被引量

Alert me when the article has been cited

提交

Tools

Publicity Resources

Exploration on mechanism of Baitouweng Decoction against colorectal adenoma based on network pharmacology and experimental validation

Exploration on molecular mechanism of Fructus Psoraleae in treating lung adenocarcinoma based on network pharmacology and experimental pharmacology

Exploration on mechanism of Wuling Powder combined with Taohong Siwu Decoction in treatment of heart failure based on network pharmacology， molecular docking， and experimental validation

Exploration on mechanism of Shaoyao Gancao Decoction in treating ulcerative colitis based on network pharmacology and in vitro cell experiments

Exploring mechanism of Mori Folium⁃Carthami Flos on type 2 diabetes based on network pharmacology

Related Author

No data

Related Institution

Institute of Digestive Diseases， Longhua Hospital， Shanghai University of Traditional Chinese Medicine

Shanghai Pudong New Area Hospital of Traditional Chinese Medicine

Shuguang Hospital Affiliated to Shanghai University of Traditional Chinese Medicine

Shanghai Municipal Hospital of Traditional Chinese Medicine， Shanghai University of Traditional Chinese Medicine

Institute of Interdisciplinary Integrative Medicine Research， Shanghai University of Traditional Chinese Medicine

⁰

Literature mining and bioinformatics analysis of Xue Xue’s Medical Cases for differentiation and treatment of gastrointestinal diseases

DOI：10.16306/j.1008-861x.2023.01.011

摘要

Abstract

关键词

Keywords

references